Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity

By Ennever F.K.   Lave L.B.  

Regulatory Toxicology and Pharmacology, Vol. 38, Iss. 1, 2003-08 ,pp. : 52-57

Elsevier

Access to resources Recommend Favorite

Carcinogenicity Testing and the Evaluation of Regulatory Requirements for Pharmaceuticals

By Contrera J.F.   Jacobs A.C.   deGeorge J.J.  

Regulatory Toxicology and Pharmacology, Vol. 25, Iss. 2, 1997-04 ,pp. : 130-145

Academic Press

Access to resources Recommend Favorite

Translational Research in Oncology: The Need of Additional In Vitro Preclinical Testing Methods for New Drugs

By  

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3416-3420

Bentham Science Publishers

Access to resources Recommend Favorite

Statistical Procedures to Test for Linearity and Estimate Threshold Doses for Tumor Induction with Nonlinear Dose–Response Relationships in Bioassays for Carcinogenicity

By Lutz R.W.   Stahel W.A.   Lutz W.K.  

Regulatory Toxicology and Pharmacology, Vol. 36, Iss. 3, 2002-12 ,pp. : 331-337

Academic Press

Access to resources Recommend Favorite

Chronic Inhalation Toxicity and Carcinogenicity Testing of Respirable Fibrous Particles

By Vu V.   Barrett J.C.   Roycroft J.   Schuman L.   Dankovic D.   BBaro P.   Martonen T.   Pepelko W.   Lai D.  

Regulatory Toxicology and Pharmacology, Vol. 24, Iss. 3, 1996-12 ,pp. : 202-212

Academic Press

Access to resources Recommend Favorite